Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Phase of Trial: Phase I/II
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid abuse
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 04 Oct 2016 Status changed from active, no longer recruiting to completed.
- 07 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.